
CAR T-Cell Therapy Can Now Target Solid Tumors: Mouse Study
June 21, 2016 (Medical News Today) In Phase 2 trials, chimeric antigen receptors (CARs), genetically engineered protein constructs, rewire T-cells in a patient’s own immune system to recognize and destroy …
CAR T-Cell Therapy Can Now Target Solid Tumors: Mouse Study Read More